Five Advanced Therapeutics to Watch in 2025

In recent years, the FDA has continued to ramp up its activities around cell therapies, gene therapies, and other advanced therapeutics as more of them progress through the pipeline for the treatment of rare, complex, and otherwise challenging diseases and disorders. . This year is shaping up to continue the trend, with a number of Prescription Drug User Fee Act (PDUFA) dates already slated for the first quarter of 2025, and several other major FDA actions likely to occur later in the year. To kick off the new year, the CGTLive^® team has highlighted 5 notable therapies to keep an eye on as the year unfolds.